logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Erlotinib/osimertinibAcquired clinical drug resistance: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2022年 / 1899卷 / 1期
关键词:
D O I:
10.1007/s40278-022-12159-0
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:185 / 185
相关论文
共 50 条
  • [1] Erlotinib/osimertinibAcquired drug resistance: case report
    Reactions Weekly, 2020, 1826 (1) : 127 - 127
  • [2] Erlotinib/osimertinibAcquired resistance: case report
    Reactions Weekly, 2021, 1880 (1) : 179 - 179
  • [3] Erlotinib/osimertinibAcquired resistance: case report
    Reactions Weekly, 2022, 1916 (1) : 198 - 198
  • [4] Crizotinib/erlotinib/osimertinibAcquired drug resistance in pulmonary adenocarcinoma: case report
    Reactions Weekly, 2018, 1721 (1) : 96 - 96
  • [5] Erlotinib/osimertinibAcquired drug resistance, acneform rashes and skin dryness: case report
    Reactions Weekly, 2021, 1855 (1) : 155 - 155
  • [6] Erlotinib/osimertinibAcquired drug resistance: 2 case reports
    Reactions Weekly, 2019, 1753 (1) : 161 - 161
  • [7] OsimertinibAcquired drug resistance : case report
    Reactions Weekly, 2025, 2047 (1) : 363 - 363
  • [8] OsimertinibAcquired drug resistance: case report
    Reactions Weekly, 2024, 2022 (1) : 222 - 222
  • [9] OsimertinibAcquired drug resistance: case report
    Reactions Weekly, 2019, 1769 (1) : 336 - 336
  • [10] OsimertinibAcquired drug resistance: case report
    Reactions Weekly, 2022, 1929 (1) : 516 - 516
← 12345 →